Breast Cancer 2012 – New Aspects
Identifieur interne : 006C19 ( Ncbi/Checkpoint ); précédent : 006C18; suivant : 006C20Breast Cancer 2012 – New Aspects
Auteurs : H.-C. Kolberg ; D. Lüftner ; M. P. Lux ; N. Maass ; F. Schütz ; P. A. Fasching ; T. Fehm ; W. Janni ; S. KümmelSource :
- Geburtshilfe und Frauenheilkunde [ 0016-5751 ] ; 2012.
Abstract
Treatment options as well as the characteristics for therapeutic decisions in patients with primary and advanced breast cancer are increasing in number and variety. New targeted therapies in combination with established chemotherapy schemes are broadening the spectrum, however potentially promising combinations do not always achieve a better result. New data from the field of pharmacogenomics point to prognostic and predictive factors that take not only the properties of the tumour but also inherited genetic properties of the patient into consideration. Current therapeutic decision-making is thus based on a combination of classical clinical and modern molecular biomarkers. Also health-economic aspects are more frequently being taken into consideration so that health-economic considerations may also play a part. This review is based on information from the recent annual congresses. The latest of these are the 34th San Antonio Breast Cancer Symposium 2011 and the ASCO Annual Meeting 2012. Among their highlights are the clinically significant results from the CLEOPATRA, BOLERO-2, EMILIA and SWOG S0226 trials on the therapy for metastatic breast cancer as well as further state-of-the-art data on the adjuvant use of bisphosphonates within the framework of the ABCSG-12, ZO-FAST, NSABP-B34 and GAIN trials.
Url:
DOI: 10.1055/s-0032-1315131
PubMed: 25324576
PubMed Central: 4168404
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000051
- to stream Pmc, to step Curation: 000051
- to stream Pmc, to step Checkpoint: 002B42
- to stream Ncbi, to step Merge: 006C19
- to stream Ncbi, to step Curation: 006C19
Links to Exploration step
PMC:4168404Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Breast Cancer 2012 – New Aspects</title>
<author><name sortKey="Kolberg, H C" sort="Kolberg, H C" uniqKey="Kolberg H" first="H.-C." last="Kolberg">H.-C. Kolberg</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Luftner, D" sort="Luftner, D" uniqKey="Luftner D" first="D." last="Lüftner">D. Lüftner</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Lux, M P" sort="Lux, M P" uniqKey="Lux M" first="M. P." last="Lux">M. P. Lux</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Maass, N" sort="Maass, N" uniqKey="Maass N" first="N." last="Maass">N. Maass</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Schutz, F" sort="Schutz, F" uniqKey="Schutz F" first="F." last="Schütz">F. Schütz</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Fasching, P A" sort="Fasching, P A" uniqKey="Fasching P" first="P. A." last="Fasching">P. A. Fasching</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Fehm, T" sort="Fehm, T" uniqKey="Fehm T" first="T." last="Fehm">T. Fehm</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Janni, W" sort="Janni, W" uniqKey="Janni W" first="W." last="Janni">W. Janni</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Kummel, S" sort="Kummel, S" uniqKey="Kummel S" first="S." last="Kümmel">S. Kümmel</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">25324576</idno>
<idno type="pmc">4168404</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168404</idno>
<idno type="RBID">PMC:4168404</idno>
<idno type="doi">10.1055/s-0032-1315131</idno>
<date when="2012">2012</date>
<idno type="wicri:Area/Pmc/Corpus">000051</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000051</idno>
<idno type="wicri:Area/Pmc/Curation">000051</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000051</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002B42</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002B42</idno>
<idno type="wicri:Area/Ncbi/Merge">006C19</idno>
<idno type="wicri:Area/Ncbi/Curation">006C19</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">006C19</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Breast Cancer 2012 – New Aspects</title>
<author><name sortKey="Kolberg, H C" sort="Kolberg, H C" uniqKey="Kolberg H" first="H.-C." last="Kolberg">H.-C. Kolberg</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Luftner, D" sort="Luftner, D" uniqKey="Luftner D" first="D." last="Lüftner">D. Lüftner</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Lux, M P" sort="Lux, M P" uniqKey="Lux M" first="M. P." last="Lux">M. P. Lux</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Maass, N" sort="Maass, N" uniqKey="Maass N" first="N." last="Maass">N. Maass</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Schutz, F" sort="Schutz, F" uniqKey="Schutz F" first="F." last="Schütz">F. Schütz</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Fasching, P A" sort="Fasching, P A" uniqKey="Fasching P" first="P. A." last="Fasching">P. A. Fasching</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Fehm, T" sort="Fehm, T" uniqKey="Fehm T" first="T." last="Fehm">T. Fehm</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Janni, W" sort="Janni, W" uniqKey="Janni W" first="W." last="Janni">W. Janni</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Kummel, S" sort="Kummel, S" uniqKey="Kummel S" first="S." last="Kümmel">S. Kümmel</name>
<affiliation><nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">Geburtshilfe und Frauenheilkunde</title>
<idno type="ISSN">0016-5751</idno>
<idno type="eISSN">1438-8804</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Treatment options as well as the characteristics for therapeutic decisions in patients with primary and advanced breast cancer are increasing in number and variety. New targeted therapies in combination with established chemotherapy schemes are broadening the spectrum, however potentially promising combinations do not always achieve a better result. New data from the field of pharmacogenomics point to prognostic and predictive factors that take not only the properties of the tumour but also inherited genetic properties of the patient into consideration. Current therapeutic decision-making is thus based on a combination of classical clinical and modern molecular biomarkers. Also health-economic aspects are more frequently being taken into consideration so that health-economic considerations may also play a part. This review is based on information from the recent annual congresses. The latest of these are the 34th San Antonio Breast Cancer Symposium 2011 and the
ASCO Annual Meeting 2012. Among their highlights are the clinically significant results from the CLEOPATRA, BOLERO-2, EMILIA and SWOG S0226 trials on the therapy for metastatic breast cancer as well as further state-of-the-art data on the adjuvant use of bisphosphonates within the framework of the ABCSG-12, ZO-FAST, NSABP-B34 and GAIN trials.</p>
</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Fasching, P A" sort="Fasching, P A" uniqKey="Fasching P" first="P. A." last="Fasching">P. A. Fasching</name>
<name sortKey="Fehm, T" sort="Fehm, T" uniqKey="Fehm T" first="T." last="Fehm">T. Fehm</name>
<name sortKey="Janni, W" sort="Janni, W" uniqKey="Janni W" first="W." last="Janni">W. Janni</name>
<name sortKey="Kolberg, H C" sort="Kolberg, H C" uniqKey="Kolberg H" first="H.-C." last="Kolberg">H.-C. Kolberg</name>
<name sortKey="Kummel, S" sort="Kummel, S" uniqKey="Kummel S" first="S." last="Kümmel">S. Kümmel</name>
<name sortKey="Luftner, D" sort="Luftner, D" uniqKey="Luftner D" first="D." last="Lüftner">D. Lüftner</name>
<name sortKey="Lux, M P" sort="Lux, M P" uniqKey="Lux M" first="M. P." last="Lux">M. P. Lux</name>
<name sortKey="Maass, N" sort="Maass, N" uniqKey="Maass N" first="N." last="Maass">N. Maass</name>
<name sortKey="Schutz, F" sort="Schutz, F" uniqKey="Schutz F" first="F." last="Schütz">F. Schütz</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006C19 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 006C19 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Checkpoint |type= RBID |clé= PMC:4168404 |texte= Breast Cancer 2012 – New Aspects }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:25324576" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |